From May 30, 2022 to May 31, 2022, the company has repurchased 22,700 shares, representing 0.67% for ¥29.21 million. With this, the company has completed the repurchase of 22,700 shares, representing 0.67% for ¥29.21 million under the buyback announced on May 30, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
998 JPY | +0.71% | -7.16% | -0.30% |
1st Jan change | Capi. | |
---|---|---|
-0.30% | 21.58M | |
-5.44% | 9.26B | |
+32.36% | 1.34B | |
-7.54% | 367M | |
+3.15% | 271M | |
+12.22% | 231M | |
-6.42% | 87.11M | |
+19.73% | 59.57M |
- Stock Market
- Equities
- 9776 Stock
- News Sapporo Clinical Laboratory Inc.
- Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on May 30, 2022.